MKC-204

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMKC-204
Drug Alias Nameinositol-requiring enzyme-1 alpha inhibitors (MannKind)IRE-1 alpha inhibitors (MannKind)MKC-204MKC-4500
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsSerine/threonine-protein kinase/endoribonuclease IRE1 inhibitorsApoptosis stimulants
TargetsSerine/threonine-protein kinase/endoribonuclease IRE1
Therapy Area/IndicationsAutoimmune DiseasesMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMannKind Corp
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A